Gain Therapeutics Inc.
06/25/2026 | Press release | Distributed by Public on 06/25/2026 15:01
Proxy Results (Form 8-K)
| Item 5.07 | Submission of Matters to a Vote of Security Holders |
On June 24, 2026, Gain Therapeutics, Inc. (the "Company") held its annual meeting of stockholders (the "Annual Meeting"), at which a quorum was present. The matters voted on at the Annual Meeting were: (1) the election of seven directors, and (2) the ratification of the appointment of Ernst & Young AG as the Company's independent registered public accounting firm. The final voting results were as follows:
1. The election of Gene Mack, Dov Goldstein, M.D., Hans Peter Hasler, Khalid Islam, Ph.D., Gwen Melincoff, Claude Nicaise, M.D., and Jeffrey Riley as directors to hold office for a term of one year, until their successors are duly elected and qualified or they are otherwise unable to complete their respective terms. The votes were cast for this matter were as follows:
| Nominee | For | Withheld | Broker Non-Vote | |||||||||
| Gene Mack | 13,618,503 | 1,691,620 | 11,670,126 | |||||||||
| Dov Goldstein, M.D. | 14,477,046 | 833,077 | 11,670,126 | |||||||||
| Hans Peter Hasler | 13,517,744 | 1,792,379 | 11,670,126 | |||||||||
| Khalid Islam, Ph.D. | 14,393,372 | 916,751 | 11,670,126 | |||||||||
| Gwen Melincoff | 14,459,942 | 850,181 | 11,670,126 | |||||||||
| Claude Nicaise, M.D. | 14,472,350 | 837,773 | 11,670,126 | |||||||||
| Jeffrey Riley | 14,148,296 | 1,161,827 | 11,670,126 | |||||||||
2. The proposal to ratify the appointment of Ernst & Young AG as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 was approved based upon the following votes:
| For | Against | Abstain | ||
| 25,865,468 | 1,074,319 | 40,462 |
Gain Therapeutics Inc. published this content on June 25, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on June 25, 2026 at 21:01 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]